: iStockAnalyst.com Symbols Feed

Bret Barakett's Tremblant Capital Group Bets On Technology: 13F Filing Q1 2009

Wed, 10 Jun 2009 16:15:00 GMT

This is the 1st Quarter 2009 edition of our ongoing hedge fund portfolio tracking series. Before reading this update, make sure you check out the Hedge Fund 13F filings series preface. Next up, we have Tremblant Capital Group. Tremblant is a $3 billion hedge fund based in New York and is run by Bret Barakett, who is a former portfolio manager at Moore Capital Management (the hedge fund run by the great Louis Bacon, whom we also track). If the last name of 'Barakett' sounds familiar, its because his brother, Timothy Barakett, manages fellow hedge fund Atticus Capital, whose portfolio we recently covered. Taken from their site, Tremblant Capital Group's objective is "to achieve superior risk adjust returns[More...]

Weekly Mergers and Acquisitions Report (Jan 28 - Feb 2)

Wed, 04 Feb 2009 13:25:23 GMT

Weekly Mergers and Acquisitions Report.[More...]

54 Stocks Returning 15%+ in January

Sun, 01 Feb 2009 18:18:00 GMT

As we exit the worst January ever, I thought it would be interesting to take a look at the best performers of the past month. Before we do, courtesy of Dshort.com this is a chart that has been passed around a lot in the investing community so I thought I'd share it. Two ways to read this - of the 4 great bear markets the past 100 years, 3 "ended" roughly where we are now... about a 50% loss in value from peak. That's the bullish view i.e. "can't get worse than this" and if we fall to S&P 750 (November lows) but never break through they will be correct. The bearish view is - the 4th bear market ended in a 90% drop, and if you plot the velocity of the decline, what happened to us in Sep - Nov caused us to be in lockstep with the worst of the 4. I'm not calling for a 90% drop[More...]

12 Stocks With Happy Investors In The New Year

Tue, 13 Jan 2009 18:37:11 GMT

Seven trading days into 2009 the stock market has returned to the bad old ways of 2008. At least for investors on the long side. As we wait for earnings season to get into gear and see if our favorite stocks can buck the trend and show positive earnings[More...]

Wall Street Declines On Earnings Fear, Financials Sink

Mon, 12 Jan 2009 20:27:14 GMT

US stocks dropped on Monday on concerns that the pain on economic front will be further compounded by dismal corporate quarterly results.[More...]

Abbott To Buy Advanced Medical Optics To Expand Medical Device Business

Mon, 12 Jan 2009 12:20:00 GMT

Medical products and drug maker Abbott Laboratories (NYSE: ABT) announced on Monday that it would acquire California-based contact lens solution makers, Advanced Medical Optics (NYSE: EYE) for $22 a share, or about $2.8 billion in cash.[More...]

US Stock Futures Slip On Profit Worries, Alcoa In Focus

Mon, 12 Jan 2009 11:54:31 GMT

US stock futures edged lower on Monday as investors remained worried about weak corporate profits.[More...]

Earnings Review – Oct 31

Fri, 31 Oct 2008 16:24:00 GMT

Advanced Medical Optics (NYSE:EYE) today announced financial results for the third quarter of 2008. Third-quarter net sales rose 1.0% to $275.6Mn; including a 2.7% increase related to foreign currency exchange rate effects.[More...]

EYE Shares Seen as a Hold - Analyst Blog

Tue, 21 Oct 2008 18:17:00 GMT

Advanced Medical Optics (EYE) announced reduced management guidance for 2008 due primarily to weaker-than-expected refractive procedures and system sales in the U.S. and Europe from declining economic conditions and weaker-than-expected eye care sales. We have lowered our FY08/FY09 estimates. The company is scheduled to report third-quarter results on October 31. At its current price of $7.50 per share, AMO is trading at 8x our 2009 earnings estimate of $0.94 per share and roughly a 0.4x P/E/G on 2009 EPS estimate, at a discount to the peer group. Growth in 2008 is expected to be negatively impacted by an elective refractive procedure market that is weakening in the U.S and Europe due to declining economic conditions, by global system sales and by reduced expected growth in refractive intraocular lens sales. Despite declining U.S.[More...]

Analyst Comments: Eli Lilly, St. Joe, Diamond Offshore, MannKind, Advanced Medical, The Washington Post

Fri, 11 Jul 2008 14:24:00 GMT

On July 9, Eli Lilly (LLY) announced the decision to acquire all outstanding shares of SGX Pharmaceuticals Inc (SGXP) at $3 per share. SGX shifted its focus to the FAST programs after the discontinuation of its only candidate Troxatyl for third-line acute[More...]

Swamped in Floyd County: Flood Waters Push Sewage into Homes

Wed, 05 Aug 2009 21:47:00 GMT

Aug. 5--Several residents told the New Albany City Council Monday they feared any prediction of rain due to flooding problems that have been especially brutal this summer.
Tuesday morning record downpours sent city and Floyd County rescue personnel scurrying to respond to trapped motorists, flooded homes and fire alarms.
Residents around New Albany could be found pumping water out of their basements and doing the best they could to salvage their valuables.

: iStockAnalyst.com Symbols Feed

Bret Barakett's Tremblant Capital Group Bets On Technology: 13F Filing Q1 2009

Weekly Mergers and Acquisitions Report (Jan 28 - Feb 2)

54 Stocks Returning 15%+ in January

12 Stocks With Happy Investors In The New Year

Wall Street Declines On Earnings Fear, Financials Sink

Abbott To Buy Advanced Medical Optics To Expand Medical Device Business

US Stock Futures Slip On Profit Worries, Alcoa In Focus

Earnings Review – Oct 31

EYE Shares Seen as a Hold - Analyst Blog

Analyst Comments: Eli Lilly, St. Joe, Diamond Offshore, MannKind, Advanced Medical, The Washington Post

Swamped in Floyd County: Flood Waters Push Sewage into Homes

Toledo Woman Takes Top Spot: Drug Stock Boosts Portfolio to 117% Gain

Top Spot in Yearlong Stock Game Holds Tight: Key Choice at Start Yielded Big Gains

Tiffin Man Commands Lead in Stock Competition: Portfolio Gain is 58% in Blade Market Game

Abbott’s Subsidiary Successfully Completes AMO Tender Offer

The Great Gravel Debate

Is It a Buy or 'Bye'?

Movers: MetLife, IBM, National City, TJX Companies

Middletown Journal, Ohio, Business Briefs Column

Advanced Medical Optics, Inc. Announces Expiration and Results of Tender Offer and Consent Solicitation for Its 7½% Senior Subordinated Notes Due 2017

Advanced Medical Optics Announces Fourth-Quarter and Full-Year 2008 Results

Advanced Medical Optics, Inc. Announces Increase in Total Consideration and Extension of Consent Deadline in Tender Offer and Consent Solicitation for Its 7½% Senior Subordinated Notes Due 2017

Advanced Medical Optics, Inc. Gives Notice of Anticipated Fundamental Change and Merger to Holders of Convertible Senior Subordinated Notes

Advanced Medical Optics, Inc. Announces Tender Offer and Consent Solicitation for Its 7½% Senior Subordinated Notes Due 2017

Levi & Korsinsky, LLP Announces Class Action Against Advanced Medical Optics, Inc. -- EYE

Advanced Medical Optics Receives FDA Approval for TECNIS® Multifocal Intraocular Lens

Zacks Analyst Blog Highlights: Yum! Brands, McDonald's, Advanced Medical Optics, Inc., Or AMO, Abbott Laboratories and The Hain Celestial Group, Inc.

BenchmarkJournal.Com (Complimentary) Analyst Review for HSC, LLY, EYE and SPLS

Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO)

Form 4 MAZZO JAMES V For: Feb 25 (10K)

Form 4 MEIER RICHARD A For: Feb 25 (10K)

Form 4 DeRisio Richard J. For: Feb 25 (10K)

Form 4 Waterhouse Alan For: Feb 25 (10K)

Form 4 ABBOTT MEDICAL OPTICS For: Feb 25 Filed by: LAMBERT MICHAEL (10K)

Form 4 ARONSON SHEREE L For: Feb 25 (10K)

Form 4 WEISNER AIMEE S For: Feb 25 (10K)

Form 4 ABBOTT LABORATORIES For: Feb 26 (10K)

Form 4 ROLLANS JAMES O For: Feb 25 (10K)

Form 4 PALMISANO ROBERT J For: Feb 25 (10K)